Medicare now negotiating price of drug that costs $7,100 in U.S. vs. $900 in Canada – CTV
Feb. 7, 2024
Sen. Bernie Sanders is once again taking the pharmaceutical industry to task, issuing a report Tuesday that highlights the cost of three blockbuster drugs that are far pricier in the U.S. than in other countries.
The differences are striking. The annual list price of Bristol Myers Squibb’s Eliquis, a blood thinner that reduces the risk of stroke, is $7,100 in the U.S. But in Japan, it’s US$940; in Canada, it’s US$900; in Germany, it’s US$770; in the United Kingdom, it’s US$760; and in France, it’s US$650.
Johnson & Johnson’s arthritis drug Stelara carries an annual list price of $79,000 in the U.S. In Germany, it’s US$30,000; in Canada, it’s US$20,000; in the U.K., it’s US$16,000; in Japan, it’s US$14,000; and in France, it’s US$12,000.
